Long-Term Outcomes in Kidney Transplant

The Need to Challenge the Status Quo

  • Tuesday, June 4, 2024
  • 12:15 pm - 1:15 pm ET
  • Philadelphia Marriott Downtown
  • Room: Salon HIJ (Level 5)
  • 1200 Filbert Street | Philadelphia, PA 19107
  • CME
  • In-Person

Kidney transplantation is currently the gold standard of care and provides patients with end-stage kidney disease the best chance for long-term, dialysis-free survival, but in addition to challenges regarding organ availability is the challenge of optimizing allograft survival over time. Join our expert panel as they review the long-term challenges of graft survival in kidney transplant recipients and the importance of understanding the patient experience and achieving better long-term outcomes.

This symposium is not part of the ATC official educational program and the sessions and content are not endorsed by ATC.

Speaker Image
Matthew Cooper, MD

Chief of Transplantation
Director of Solid Organ Transplant
Professor of Surgery
Medical College of Wisconsin
Milwaukee, Wisconsin

Speaker Image
Richard Formica, MD

Professor of Medicine (Nephrology) and Professor of Surgery (Transplant)
Director of Transplant Medicine
Director of Outpatient Transplantation Service
Medical Director of Adult Kidney Transplantation
Yale School of Medicine
New Haven, Connecticut

Speaker Image
Edward Hickey, III

American Association of Kidney Patients
AAKP Veterans Health Initiative
Retired USMC
Westlake Village, California

Speaker Image
Vineeta Kumar, MD

Professor of Medicine
Division of Nephrology/Transplant Nephrology
Clinical Director, Renal Module
Core Clinical Faculty
UAB Tinsley Harrison Internal Medicine Residency
University of Alabama
Birmingham, Alabama


11:45 AM

Registration and Lunch

12:15 PM

Welcome and Introductions

Matthew Cooper, MD

12:20 PM

Unmet Needs in Transplantation

Matthew Cooper, MD
Richard Formica, MD
Vineeta Kumar, MD
Edward Hickey, III

Strategies to Maximize the Life of the Transplant

Matthew Cooper, MD
Richard Formica, MD
Vineeta Kumar, MD
Edward Hickey, III

Future of Immunosuppression: Therapeutic Targets in the Costimulatory Pathways

Matthew Cooper, MD
Richard Formica, MD
Vineeta Kumar, MD

01:00 PM

Concluding Remarks

Matthew Cooper, MD

01:05 PM

Audience Q&A

All Panel

Room: Grand Ballroom AB - 3rd Floor
Intercontinental San Francisco | San Francisco, CA
Get Directions
Program Information
Accreditation Statement

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Accreditation logos
Accreditation logos
For Physicians

Medscape, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

Upon completion of this activity, participants will:

Have increased knowledge regarding the

  • Suboptimal long-term graft outcomes for kidney transplant recipients
  • Limitations of current immunosuppressive treatment protocols

Have greater competence related to

  • Identifying impactful future clinical trial design

Demonstrate greater confidence in their ability to

  • Tailor calcineurin inhibitors to optimize efficacy, safety, and adherence
Goal Statement

The goal of this activity is for learners to be better able to review long-term outcomes of kidney transplantation and strategies to maximize the life of the transplanted organ.

Target Audience

This activity is intended for transplant surgeons, nephrologists, surgeons, and other healthcare practitioners who treat patients who are candidates for, or recipients of kidney transplantation.

Supported by an independent educational grant from Veloxis.